Colorado Confirmed as Top Bioscience State by National Rankings

It’s been a banner year for Colorado in the highly competitive state rankings arena. Genome Technology’s June publication ranks Colorado as one of the top 20 biotech locations in the world and the Families USA Global Health Initiative Report ranked Colorado fourth among states that generated the most economic activity per dollar of funding from the NIH. Further, Colorado placed in the top five of all five categories in the Milken Institute’s State Technology and Science Index, moving ahead of California in the new overall rankings. Milken ranked Colorado second in the concentration of scientists and engineers.

FDA Clears First Automated Whole Blood Processing System In U.S.

Atreus® Whole Blood Processing System simplifies processes, increases product quality and enhances regulatory compliance

LAKEWOOD, CO - Gambro BCT, Inc., soon to be known as CaridianBCT, a leading global provider of technology, products and services in automated blood collections, therapeutic systems, whole blood processes and pathogen reduction technologies, announced today that it received FDA clearance for the commercial sale of Atreus® Whole Blood Processing system in the United States. The Atreus system is the first self-contained, automated manufacturing system cleared for distribution in the U.S.

FierceBiotech Names GlobeImmune as One of the "Fierce 15" Biotech Companies of 2008

GlobeImmune is "Fierce," on Leading Edge of Biotech

LOUISVILLE, CO - FierceBiotech and GlobeImmune announced today that GlobeImmune has been named to the annual FierceBiotech "Fierce 15" list, designating it as one of the top biotech companies of 2008. The editors of FierceBiotech evaluated hundreds of privately-held firms based on company vision, revenue potential, quality of deals, strength of technology, partnerships, and competitive market position. GlobeImmune was determined to be one of the "fiercest," proven by their creativity and innovations in the industry.

Boulder biotechs expanding

Two Boulder-based biotechnology firms are expanding their businesses in Boulder.

Colorado’s Bioscience Community Celebrates The State’s Largest Medical Device Manufacturer

Gambro BCT, Inc., (to be CaridianBCT, Inc., as of July 14) is the largest medical device manufacturer headquartered in Colorado, with worldwide revenues approaching $500M and 2300 employees. The company had previously been a subsidiary of Gambro AB, a publicly traded, multinational healthcare company based in Sweden. The name CaridianBCT combines two words “care” and “meridian” to highlight the manufacturer's commitment to care and global reach.

US – Israel Binational R&D Foundation Approves Funding of Joint Venture WIM-GER™ Development

Sandhill Scientific, Inc. of Denver, Colorado USA and KarmelSonix Ltd (ASX: KSX) and its Haifa, Israel - based subsidiary, KarmelSonix (Israel) Ltd. are pleased to announce the approval of funding by the United States – Israel Industrial Research and Development Foundation (BIRD-F) for their joint venture to co-develop, validate and bring to market the WIM-GER™.

Baxa Corporation Named Finalist for Third Year as a Best Company to Work For in Colorado

Englewood-based Baxa Corporation has been named a finalist in the 3rd Annual Best Companies to Work for in Colorado competition. This is the company’s third consecutive year as a finalist in the large company category.

Gene Check Receives Two Federally-Funded Research Grants

GREELEY, CO. June 9, 2008. Gene Check, Inc. has been awarded two research grants to develop methods of mutation detection and genotyping. Both are from the National Institutes of Health Small Business Innovation Research Program and both will utilize elements of Gene Check’s patented RecA-mediated ligation (RML) technology.

Anschutz Medical Campus still growing

One building opened and another is scheduled to break ground at the still-growing Anschutz Medical Campus.

Holland & Hart singled out by corporate directors

An annual study of the best corporate law firms named Holland & Hart the best in Denver.

MEDdevice Acquisition Co., LLC and Epsilon Securities, LLC Identify Sources of Funding

BOULDER - MEDdevice Acquisition Co., LLC ("MDAC") and Epsilon Securities, LLC are proud to announce that they have identified sources of funding to finance their acquisition strategy in the medical device industry.

SomaLogic expanding; Tapestry closing

BOULDER - While one Boulder-based biotech is rapidly growing, another is slowly going away.

Baxa Corporation Launches PACT™ Product Line at the ASHP Summer Meeting

Baxa is promoting its new PACT (Productivity and Compliance Tools) product line at the American Society of Health-System Pharmacists 2008 Summer Meeting and Exhibition beginning today at the Washington State Convention and Trade Center in Seattle. The PACT line includes products and services designed to help pharmacies improve patient-care efficiencies and simplify compliance with state and federal regulations.

HKH'S CORPORATE AND SECURITIES PRACTICE ADDS EXPERIENCE AND DEPTH

Hensley Kim & Holzer (www.hkh-law.com), a Denver-based law firm providing expert legal counsel representing companies of all sizes in the areas of business, securities, intellectual property, litigation and real estate law, enhances its Corporate and Securities practice with the addition of the Corporate and Securities group from the Denver office of Solomon Pearl Blum Heyman & Stich LLP, which closed its doors at the end of May 2008.

Gambro BCT Soon To Become CaridianBCT

New name and identity to reflect company’s operational independence and global stature as a leading medical device manufacturer

CU hospital receives major grant

AURORA — A nationwide effort to reduce the time it takes for laboratory discoveries to become treatments for patients has resulted in a $76 million, five-year grant to the University of Colorado Health Sciences Center.

Allos prices offering at $5.64 a share

Allos Therapeutics Inc. on Friday announced a per-share price of $5.64 for its pending public offering of stock.

Accelr8 and BD Sign Research and Licensing Option Agreement for Commercializing Accelr8’s BACcel™ Rapid Diagnostics Technology

DENVER, Colo., May 20, 2008 – Accelr8 Technology Corporation (AMEX: AXK) announced today that it has signed an agreement with BD (Becton, Dickinson and Company) with respect to Accelr8’s BACcel™ rapid pathogen diagnostics platform.

Encision improves sales, profits

BOULDER - Encision Inc. reported its fourth quarter 2008 revenues up 13 percent with a profit versus a loss from a year ago.

The Natural Artificial Foot

Jerome Rifkin's K3 Promoter mimics the jointed motion of a real foot for easier walking.

AlphaSniffer changes the name to BiOptix.

AlphaSniffer LLC, a privately held company commercializing new technologies for rapid, sensitive, label-free detection of biomarkers, announced today that a majority of shareholders and the Board of Directors have approved a name change from AlphaSniffer to BiOptix.

BioForm Medical Acquires Facial Aesthetic Nerve Ablation Technology

Technology designed to selectively weaken specific muscles may provide an attractive alternative treatment for frown lines

MEDdevice Acquisition Co., LLC Announces Board Members and Advisors

AURORA, Colo., /PRNewswire/ -- MEDdevice Acquisition Co., LLC MDAC is proud to announce that it has engaged a highly experienced team with deep domain experience and proven success optimizing investments in the medical device market as board members and advisors.

Beakers to the Rescue

Scientists say a new green revolution could head off future food crises.

Epsilon Securities, LLC, to Provide M&A Advisory Services to MEDdevice Acquisition Co., LLC

AURORA, Colo., /PRNewswire/ -- MEDdevice Acquisition Corporation, LLC ("MDAC") is proud to announce that it has retained Epsilon Securities, LLC as M&A advisor in its focus to build a significant enterprise in one or more select medical device sectors of the medical device industry.

Patrick Gruber, CEO of Gevo, Inc. Receives George Washington Carver Award at BIO's World Congress

During a plenary lunch of the World Congress on Industrial Biotechnology and Bioprocessing, BIO presented the first annual George Washington Carver Award to Dr. Patrick Gruber, CEO, Gevo, Inc., recognizing his accomplishments in creating and commercializing a new plastic made from annually renewable resources.

Array BioPharma lands $80M investment

Array BioPharma Inc.said Monday the $80 million received from a large shareholder will help the company move six drug programs through clinical proof-of-concept studies.

OPX to commercialize CU technology

BOULDER - OPX Biotechnologies Inc. in Boulder has licensed technology from the University of Colorado's Technology Transfer Office that focuses on the production of biorefined fuels and chemicals.

Biofuel research firm receives funds

LAFAYETTE - A Lafayette-based gene discovery company has received financing from a Denver-based venture capital firm to study genes that could increase biofuel crop yields.

ARCA Biopharma's new drug attacks heart disease

BROOMFIELD , CO - Personalized medicine, or the targeting of drugs to an individual's genetic makeup, is an emerging industry. Colorado-based ARCA Biopharma hopes to add an arrow to the quiver of available heart-disease therapies with one such genetically targeted treatment as early as next year.

MEDdevice Acquisition Co., LLC Engages Catalyst Financial Resources

DENVER, CO// MEDdevice Acquisition Corp., has selected Catalyst Financial Resources to execute a comprehensive investor awareness campaign aimed at increasing corporate visibility in the financial marketplace. Catalyst Financial Resources will initiate a program which includes investor conferences and institutional targeting to help promote the visibility of MEDdevice Acquisition Corp. in the financial marketplace. The contract involves extensive use of Catalyst’s proprietary process for creating, managing and developing institutional exposure to under-followed small & emerging companies.

Baxa Environmental Program Nets Significant Results

In celebration of Earth Day tomorrow, Baxa Corporation announces significant increase in environmental benefits through environmental stewardship and recycling programs.

Biopharma to add jobs in Boulder

BOULDER - Quark Pharmaceuticals Inc., a Fremont, Calif.-based pharmaceutical company, will use a portion of a round of $27 million in financing to add jobs at its research and development lab in Boulder.

Biologist with MBA working to bring drugs to market

Interview | A conversation with Rhonda Wallen, chief executive of Caveo Therapeutics, a Boulder-based biotechnology company

MONSANTO ANNOUNCES PLANNED EXPANSION AT ITS ROUNDUP FACILITY IN LULING, LOUISIANA

ST. LOUIS, April 2, 2008 — Monsanto announced today its intention to make an investment of up to $196 million over the next 18 months at its glyphosate manufacturing facility in Luling, Louisiana. The planned development will increase its global capacity to produce Roundup and other glyphosate-based herbicides.

Nobel laureate Cech to return to CU

Nobel Prize-winning biochemist Tom Cech will return to the University of Colorado at Boulder full time next year, after eight years as head of the prestigious Howard Hughes Medical Institute in Maryland.

Colo. firm snares $100 million to finish biofuels plant

Range Fuels Inc. has raised more than $100 million in private funds, propelling the Broomfield company forward in its quest to turn wood waste into motor fuel.